Literature DB >> 17481657

Galanthamine and non-competitive inhibitor binding to ACh-binding protein: evidence for a binding site on non-alpha-subunit interfaces of heteromeric neuronal nicotinic receptors.

Scott B Hansen1, Palmer Taylor.   

Abstract

Rapid neurotransmission is mediated through a superfamily of Cys-loop receptors that includes the nicotinic acetylcholine (nAChR), gamma-aminobutyric acid (GABA(A)), serotonin (5-HT(3)) and glycine receptors. A class of ligands, including galanthamine, local anesthetics and certain toxins, interact with nAChRs non-competitively. Suggested modes of action include blockade of the ion channel, modulation from undefined extracellular sites, stabilization of desensitized states, and association with annular or boundary lipid. Alignment of mammalian Cys-loop receptors shows aromatic residues, found in the acetylcholine or ligand-binding pocket of nAChRs, are conserved in all subunit interfaces of neuronal nAChRs, including those that are not formed by alpha subunits on the principal side of the transmitter binding site. The amino-terminal domain containing the ligand recognition site is homologous to the soluble acetylcholine-binding protein (AChBP) from mollusks, an established structural and functional surrogate. We assess ligand specificity and employ X-ray crystallography with AChBP to demonstrate ligand interactions at subunit interfaces lacking vicinal cysteines (i.e. the non-alpha subunit interfaces in nAChRs). Non-competitive nicotinic ligands bind AChBP with high affinity (K(d) 0.015-6 microM). We mutated the vicinal cysteine residues in loop C of AChBP to mimic the non-alpha subunit interfaces of neuronal nAChRs and other Cys loop receptors. Classical nicotinic agonists show a 10-40-fold reduction in binding affinity, whereas binding of ligands known to be non-competitive are not affected. X-ray structures of cocaine and galanthamine bound to AChBP (1.8 A and 2.9 A resolution, respectively) reveal interactions deep within the subunit interface and the absence of a contact surface with the tip of loop C. Hence, in addition to channel blocking, non-competitive interactions with heteromeric neuronal nAChR appear to occur at the non-alpha subunit interface, a site presumed to be similar to that of modulating benzodiazepines on GABA(A) receptors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17481657      PMCID: PMC2031909          DOI: 10.1016/j.jmb.2007.03.067

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  34 in total

1.  lynx1, an endogenous toxin-like modulator of nicotinic acetylcholine receptors in the mammalian CNS.

Authors:  J M Miwa; I Ibanez-Tallon; G W Crabtree; R Sánchez; A Sali; L W Role; N Heintz
Journal:  Neuron       Date:  1999-05       Impact factor: 17.173

2.  A glia-derived acetylcholine-binding protein that modulates synaptic transmission.

Authors:  A B Smit; N I Syed; D Schaap; J van Minnen; J Klumperman; K S Kits; H Lodder; R C van der Schors; R van Elk; B Sorgedrager; K Brejc; T K Sixma; W P Geraerts
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

3.  Identification of amino acid residues important for assembly of GABA receptor alpha1 and gamma2 subunits.

Authors:  Isabella Sarto-Jackson; Joachim Ramerstorfer; Margot Ernst; Werner Sieghart
Journal:  J Neurochem       Date:  2006-01-12       Impact factor: 5.372

Review 4.  Molecular mechanisms and binding site locations for noncompetitive antagonists of nicotinic acetylcholine receptors.

Authors:  Hugo R Arias; Pankaj Bhumireddy; Cecilia Bouzat
Journal:  Int J Biochem Cell Biol       Date:  2006-02-20       Impact factor: 5.085

5.  Agonist-mediated conformational changes in acetylcholine-binding protein revealed by simulation and intrinsic tryptophan fluorescence.

Authors:  Fan Gao; Nina Bren; Thomas P Burghardt; Scott Hansen; Richard H Henchman; Palmer Taylor; J Andrew McCammon; Steven M Sine
Journal:  J Biol Chem       Date:  2004-12-09       Impact factor: 5.157

6.  Modulation of nicotinic acetylcholine receptors by strychnine.

Authors:  J García-Colunga; R Miledi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

7.  A second pathway of activation of the Torpedo acetylcholine receptor channel.

Authors:  K O Okonjo; J Kuhlmann; A Maelicke
Journal:  Eur J Biochem       Date:  1991-09-15

8.  Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors.

Authors:  Marek Samochocki; Anja Höffle; Andreas Fehrenbacher; Ruth Jostock; Jürgen Ludwig; Claudia Christner; Martin Radina; Marion Zerlin; Christoph Ullmer; Edna F R Pereira; Hermann Lübbert; Edson X Albuquerque; Alfred Maelicke
Journal:  J Pharmacol Exp Ther       Date:  2003-03-20       Impact factor: 4.030

9.  Coupling of agonist binding to channel gating in an ACh-binding protein linked to an ion channel.

Authors:  Cecilia Bouzat; Fernanda Gumilar; Guillermo Spitzmaul; Hai-Long Wang; Diego Rayes; Scott B Hansen; Palmer Taylor; Steven M Sine
Journal:  Nature       Date:  2004-08-19       Impact factor: 49.962

10.  Photoaffinity labeling of Torpedo acetylcholine receptor by physostigmine.

Authors:  A Schrattenholz; J Godovac-Zimmermann; H J Schäfer; E X Albuquerque; A Maelicke
Journal:  Eur J Biochem       Date:  1993-09-01
View more
  53 in total

1.  Enhanced meta-analysis of acetylcholine binding protein structures reveals conformational signatures of agonism in nicotinic receptors.

Authors:  Spencer T Stober; Cameron F Abrams
Journal:  Protein Sci       Date:  2012-03       Impact factor: 6.725

2.  Nicotinic acetylcholine receptor transmembrane mutations convert ivermectin from a positive to a negative allosteric modulator.

Authors:  Toby Collins; Neil S Millar
Journal:  Mol Pharmacol       Date:  2010-05-12       Impact factor: 4.436

3.  Alpha-conotoxin AuIB isomers exhibit distinct inhibitory mechanisms and differential sensitivity to stoichiometry of alpha3beta4 nicotinic acetylcholine receptors.

Authors:  Anton A Grishin; Ching-I A Wang; Markus Muttenthaler; Paul F Alewood; Richard J Lewis; David J Adams
Journal:  J Biol Chem       Date:  2010-05-13       Impact factor: 5.157

4.  Negative allosteric modulators that target human alpha4beta2 neuronal nicotinic receptors.

Authors:  Brandon J Henderson; Ryan E Pavlovicz; Jerad D Allen; Tatiana F González-Cestari; Crina M Orac; Andrew B Bonnell; Michael X Zhu; R Thomas Boyd; Chenglong Li; Stephen C Bergmeier; Dennis B McKay
Journal:  J Pharmacol Exp Ther       Date:  2010-06-15       Impact factor: 4.030

5.  Acetylcholine receptor (AChR) α5 subunit variant associated with risk for nicotine dependence and lung cancer reduces (α4β2)₂α5 AChR function.

Authors:  Alexander Kuryatov; Wade Berrettini; Jon Lindstrom
Journal:  Mol Pharmacol       Date:  2010-09-29       Impact factor: 4.436

6.  The Recognition of Identical Ligands by Unrelated Proteins.

Authors:  Sarah Barelier; Teague Sterling; Matthew J O'Meara; Brian K Shoichet
Journal:  ACS Chem Biol       Date:  2015-10-12       Impact factor: 5.100

7.  Creating an α7 nicotinic acetylcholine recognition domain from the acetylcholine-binding protein: crystallographic and ligand selectivity analyses.

Authors:  Akos Nemecz; Palmer Taylor
Journal:  J Biol Chem       Date:  2011-10-18       Impact factor: 5.157

8.  Structure-activity relationship studies of sulfonylpiperazine analogues as novel negative allosteric modulators of human neuronal nicotinic receptors.

Authors:  Brandon J Henderson; Daniel J Carper; Tatiana F González-Cestari; Bitna Yi; Kiran Mahasenan; Ryan E Pavlovicz; Martin L Dalefield; Robert S Coleman; Chenglong Li; Dennis B McKay
Journal:  J Med Chem       Date:  2011-11-18       Impact factor: 7.446

9.  Additional acetylcholine (ACh) binding site at alpha4/alpha4 interface of (alpha4beta2)2alpha4 nicotinic receptor influences agonist sensitivity.

Authors:  Simone Mazzaferro; Naïl Benallegue; Anna Carbone; Federica Gasparri; Ranjit Vijayan; Philip C Biggin; Mirko Moroni; Isabel Bermudez
Journal:  J Biol Chem       Date:  2011-07-14       Impact factor: 5.157

10.  Morantel allosterically enhances channel gating of neuronal nicotinic acetylcholine alpha 3 beta 2 receptors.

Authors:  Tse-Yu Wu; Caleb M Smith; Steven M Sine; Mark M Levandoski
Journal:  Mol Pharmacol       Date:  2008-05-05       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.